These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. COVID-19 Vaccine in Children: Where Do We Stand? Kumar J; Meena J Indian Pediatr; 2021 Feb; 58(2):194-195. PubMed ID: 33632966 [No Abstract] [Full Text] [Related]
43. [Current state of vaccination against SARS-CoV-2]. Iking-Konert C; Specker C; Krüger K; Schulze-Koops H; Aries P Z Rheumatol; 2021 Mar; 80(2):158-164. PubMed ID: 33528655 [TBL] [Abstract][Full Text] [Related]
44. 'Vaccine hesitancy' among university students in Italy during the COVID-19 pandemic. Barello S; Nania T; Dellafiore F; Graffigna G; Caruso R Eur J Epidemiol; 2020 Aug; 35(8):781-783. PubMed ID: 32761440 [TBL] [Abstract][Full Text] [Related]
45. How could a COVID vaccine cause blood clots? Scientists race to investigate. Ledford H Nature; 2021 Apr; 592(7854):334-335. PubMed ID: 33846607 [No Abstract] [Full Text] [Related]
46. What does 95% COVID-19 vaccine efficacy really mean? Olliaro P Lancet Infect Dis; 2021 Jun; 21(6):769. PubMed ID: 33609458 [No Abstract] [Full Text] [Related]
47. Rebuilding public trust: a clarified response to COVID-19 vaccine hesitancy predicament. Cordero DA J Public Health (Oxf); 2021 Jun; 43(2):e303-e304. PubMed ID: 33539536 [TBL] [Abstract][Full Text] [Related]
48. COVID-19 vaccines and pregnancy: What do we know? Cottin J; Benevent J; Khettar S; Lacroix I Therapie; 2021; 76(4):373-374. PubMed ID: 34238585 [No Abstract] [Full Text] [Related]
49. Immunogenicity of a heterologous COVID-19 vaccine after failed vaccination in a lymphoma patient. Hill JA; Ujjani CS; Greninger AL; Shadman M; Gopal AK Cancer Cell; 2021 Aug; 39(8):1037-1038. PubMed ID: 34242571 [No Abstract] [Full Text] [Related]
50. Global COVID-19 vaccine equity should precede requiring travelers proof of vaccination. Franco-Paredes C; Suarez JA; Henao-Martínez AF Int J Infect Dis; 2021 Apr; 105():243-244. PubMed ID: 33640569 [No Abstract] [Full Text] [Related]
51. Social media and vaccine hesitancy. Wilson SL; Wiysonge C BMJ Glob Health; 2020 Oct; 5(10):. PubMed ID: 33097547 [TBL] [Abstract][Full Text] [Related]
52. [Clinical evaluation of a COVID-19 vaccine from a volunteer perspective]. Helguera G Medicina (B Aires); 2021; 81(1):125-126. PubMed ID: 33611258 [No Abstract] [Full Text] [Related]
53. COVID-19 Vaccine Hesitancy in the Inpatient Psychiatric Setting. Shahani L; Lane SD; Soares JC Psychiatr Serv; 2021 Nov; 72(11):1360-1361. PubMed ID: 34734751 [No Abstract] [Full Text] [Related]
54. Comment on: "Willingness to Pay for a COVID-19 Vaccine". Sprengholz P; Betsch C Appl Health Econ Health Policy; 2021 Jul; 19(4):619-621. PubMed ID: 33973148 [No Abstract] [Full Text] [Related]
55. The role of epidemiologists in communicating SARS-CoV-2 evidence: a call for adopting standards. Smith MY; Bahri P; Gaudino JA; Moreira RS; Danyluk GM; Palevsky SL Int J Epidemiol; 2021 Nov; 50(5):1410-1415. PubMed ID: 34179978 [No Abstract] [Full Text] [Related]
56. Vaccination Disparity: Quantifying Racial Inequity in COVID-19 Vaccine Administration in Maryland. Cardona S; Felipe N; Fischer K; Sehgal NJ; Schwartz BE J Urban Health; 2021 Aug; 98(4):464-468. PubMed ID: 34142349 [No Abstract] [Full Text] [Related]
57. COVID-19 Vaccine Hesitancy Among Patients With Psychiatric Disorders. Uvais NA Prim Care Companion CNS Disord; 2021 Nov; 23(6):. PubMed ID: 34738353 [No Abstract] [Full Text] [Related]
58. COVID-19 vaccine roll-out in middle-income countries: Lessons learned from the Jordan experience. Al-Shaikh A; Muthu N; Aidyralieva C; Profili MC; Bellizzi S Vaccine; 2021 Aug; 39(34):4769-4771. PubMed ID: 34281741 [No Abstract] [Full Text] [Related]